Feifei Nan
Impact in
-
- Lymphoma Diagnosis and Treatment
- Oncology top 5%
- Viral-associated cancers and disorders
- CAR-T cell therapy research
- Cancer Cells and Metastasis
Papers in
-
- Lymphoma Diagnosis and Treatment 26
- Oncology 21
- Viral-associated cancers and disorders 6
- CAR-T cell therapy research 5
- Cancer-related Molecular Pathways 3
- Co-authors
- Yu Chang (24 shared papers)Xiaorui Fu (28 shared papers)Zhaoming Li (26 shared papers)Huanle Zhang (2 shared papers)Jingjing Wu (19 shared papers)Lei Zhang (21 shared papers)Zhenchang Sun (20 shared papers)Xinhua Wang (18 shared papers)
- Journals
- Oncotarget (3 papers)Leukemia Research (3 papers)British Journal of Haematology (2 papers)Biochemical and Biophysical Research Communications (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Feifei Nan
44 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 68
- Pathology and Forensic Medicine 524
- Oncology 570
- Immunology 278
- Genetics 107
- Cancer Research 132
Countries citing papers authored by Feifei Nan
This map shows the geographic impact of Feifei Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Nan more than expected).
Fields of papers citing papers by Feifei Nan
This network shows the impact of papers produced by Feifei Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Nan. The network helps show where Feifei Nan may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Nan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 169 | |
| 2 | 2016 | 118 | |
| 3 | 2010 | 97 | |
| 4 | 2022 | 89 | |
| 5 | 2010 | 70 | |
| 6 | 2019 | 60 | |
| 7 | 2022 | 35 | |
| 8 | 2018 | 32 | |
| 9 | 2018 | 32 | |
| 10 | 2013 | 32 | |
| 11 | 2022 | 29 | |
| 12 | 2019 | 29 | |
| 13 | 2019 | 27 | |
| 14 | 2017 | 27 | |
| 15 | 2017 | 26 | |
| 16 | 2018 | 26 | |
| 17 | 2015 | 21 | |
| 18 | Targeting Six1 by lentivirus-mediated RNA interference inhibits colorectal cancer cell growth and invasion. | 2014 | 20 |
| 19 | 2016 | 19 | |
| 20 | 2018 | 18 |
About Feifei Nan
Feifei Nan is a scholar working on Pathology and Forensic Medicine, Oncology, Neurology, Immunology and Genetics, having authored 48 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (26 papers), CNS Lymphoma Diagnosis and Treatment (7 papers), Viral-associated cancers and disorders (6 papers), Immune Cell Function and Interaction (6 papers), CAR-T cell therapy research (5 papers), Cutaneous lymphoproliferative disorders research (3 papers), Cancer-related Molecular Pathways (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (524 citations), Oncology (570 citations), Immunology (278 citations), Genetics (107 citations) and Cancer Research (132 citations). Feifei Nan has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yu Chang, Xiaorui Fu, Zhaoming Li, Huanle Zhang, Jingjing Wu, Lei Zhang, Zhenchang Sun, Xinhua Wang, Jiaqin Yan and Yuqing Li. Their work appears in journals such as Oncotarget, Leukemia Research, British Journal of Haematology, Biochemical and Biophysical Research Communications and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.